OFG
BMY.RT

Oxford Financial Group’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Oxford Financial Group’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-15,538
Closed -$11K – 241
2020
Q4 		$11K Hold
15,538
– – ﹤0.01% 199
2020
Q3 		$35K Hold
15,538
– – 0.01% 173
2020
Q2 		$56K Sell
15,538
-100
-0.6% -$361 0.01% 166
2020
Q1 		$59K Buy
+15,638
New +$51.5K 0.01% 173

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Oxford Financial Group's BMY.RT Position: Q1 2021 in Review

Oxford Financial Group sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 15,538 shares — an estimated $11K sold.

Oxford Financial Group first reported a position in BMY.RT in Q1 2020 and held it in 4 quarters. The position peaked at $59K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Oxford Financial Group reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Oxford Financial Group sold 15,538 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $11K.
  • Oxford Financial Group first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q1 2020 and held it in 4 quarters.
  • Oxford Financial Group's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $59K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Oxford Financial Group's 13F filing for Q1 2021, filed 10 May 2021.